Antibacterial drug is defined as an agent that interferes with the growth and reproduction of bacteria that can cause numerous mild-to-severe infections in living organisms. Antibacterial drugs have bactericidal action. They act on various parts of the bacterial life cycle such as protein synthesis, nucleic acid synthesis, cell wall synthesis, and permeability of cell membrane. Thus, they help in treating infections. These drugs have been classified into eight major classes viz. aminoglycosides, β-lactams, tetracycline, sulfonamides, quinolones/fluoroquinolones, macrolides, and phenicols. Phenicols, a broad spectrum antibacterial drugs, is a major class of antibacterial drugs. Phenicols are bacteriostatic in their mode of action. Molecules of phenicols inhibit the elongation step of the bacterial protein synthesis by binding to peptidyl transferase. Phenicols are highly effective against gram positive, gram negative, aerobic and anaerobic bacterial strains. These drugs are specifically used to treat infections caused by Chlamydia, Mycoplasma, and Rickettsiae species. Also, this class of antibacterial drugs is not commonly prescribed to treat simple infections such as flu, cold, and sore throat and other minor infections.
Phenicols are utilized in treating serious bacterial infections (such as meningitis), wherein other medicines do not work, as these drugs are capable of crossing the blood–brain barrier. Phenicols are also employed in combination with other antibacterial drugs in order to increase the overall effectiveness of the treatment. However, they may cause some side–effects, which may lead to unusual bleeding, bruising, or eye-related problems. Growth drivers for the phenicols market include increasing prevalence of highly potent and serious bacterial infections and rising availability of generics in emerging as well as developed markets. Moreover, governments of different countries have initiated various developmental programs to accelerate innovations in antibacterial drugs in order to address the need for better treatment of harmful infections and to overcome rapid development of antibiotic-resistant species. However, patent expiry of drugs and bacterial drug resistance are major restraints for the phenicols market. Certain side-effects associated with long-term use of phenicols have also caused hindrance to use of phenicols for the treatment of infectious diseases.
The global phenicols market can be segmented based on route of administration, distribution channel, and region. Based on route of administration, the global phenicols market can be segmented into oral route and intravenous route. Based on distribution channel, the market can be divided into hospital pharmacies, retail pharmacies, and clinics.
Geographically, the global phenicols market can be segregated into five major regions: North America, Asia Pacific (APAC), Europe, Latin America, and Rest of World (RoW). Asia Pacific is expected to dominate the global phenicols market during the forecast period. Expanding health care infrastructure, rising disposable income, and large geriatric population in emerging economies such as India and China are some of the factors expected to play a key role in making Asia Pacific a highly attractive market for manufacturers operating in the phenicols market during the forecast period. Presence of leading manufacturers of generic drugs, low cost of clinical trials, and rapidly expanding pharmaceutical industry in the region would propel the market in Asia Pacific in the next few years.
New drugs are usually launched in the U.S. or Europe market before other parts of the world. This early market initiation results in a larger market share held by North America and Europe. Continuous research and development activities in the drug discovery industry would propel the phenicols market during the forecast period. Major players operating in the global phenicols market are GlaxoSmithKline plc, Sanofi, Pfizer, Inc. and Fresenius Kabi AG.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.